0001638599-19-000574.txt : 20190531 0001638599-19-000574.hdr.sgml : 20190531 20190531161644 ACCESSION NUMBER: 0001638599-19-000574 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190220 FILED AS OF DATE: 20190531 DATE AS OF CHANGE: 20190531 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kay Robert CENTRAL INDEX KEY: 0001285612 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35023 FILM NUMBER: 19870657 MAIL ADDRESS: STREET 1: C/O IBIO, INC. STREET 2: 9 INNOVATION WAY, SUITE 100 CITY: NEWARK STATE: DE ZIP: 19711 FORMER NAME: FORMER CONFORMED NAME: KAY ROBERT DATE OF NAME CHANGE: 20040331 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: iBio, Inc. CENTRAL INDEX KEY: 0001420720 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262797813 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 600 MADISON AVENUE, SUITE 1601 CITY: NEW YORK STATE: NY ZIP: 10022-1737 BUSINESS PHONE: 302 355-0650 MAIL ADDRESS: STREET 1: 600 MADISON AVENUE, SUITE 1601 CITY: NEW YORK STATE: NY ZIP: 10022-1737 FORMER COMPANY: FORMER CONFORMED NAME: iBioPharma, Inc. DATE OF NAME CHANGE: 20080806 FORMER COMPANY: FORMER CONFORMED NAME: InB:Biotechnologies, Inc. DATE OF NAME CHANGE: 20071210 4/A 1 doc4a_6128.xml PRIMARY DOCUMENT X0306 4/A 2019-02-20 2019-05-13 0 0001420720 iBio, Inc. IBIO 0001285612 Kay Robert C/O IBIO, INC. 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022 1 1 0 0 Executive Chairman and CEO Stock Option (right to buy) 6.60 2019-02-20 4 D 0 25000 D 2019-08-10 Common Stock 25000 307500 D Stock Option (right to buy) 0.93 2019-02-20 4 A 0 18750 A 2024-02-20 Common Stock 18750 307500 D Stock Option (right to buy) 17.30 2019-02-20 4 D 0 30000 D 2020-08-16 Common Stock 30000 307500 D Stock Option (right to buy) 0.93 2019-02-20 4 A 0 22500 A 2024-02-20 Common Stock 22500 307500 D Stock Option (right to buy) 30.70 2019-02-20 4 D 0 50000 D 2020-12-30 Common Stock 50000 307500 D Stock Option (right to buy) 0.93 2019-02-20 4 A 0 37500 A 2024-02-20 Common Stock 37500 307500 D Stock Option (right to buy) 30.70 2019-02-20 4 D 0 50000 D 2020-12-30 Common Stock 50000 307500 D Stock Option (right to buy) 0.93 2019-02-20 4 A 0 37500 A 2024-02-20 Common Stock 37500 307500 D Stock Option (right to buy) 19.60 2019-02-20 4 D 0 30000 D 2021-10-21 Common Stock 30000 307500 D Stock Option (right to buy) 0.93 2019-02-20 4 A 0 22500 A 2024-02-20 Common Stock 22500 307500 D Stock Option (right to buy) 11.00 2019-02-20 4 D 0 30000 D 2022-07-24 Common Stock 30000 307500 D Stock Option (right to buy) 0.93 2019-02-20 4 A 0 22500 A 2024-02-20 Common Stock 22500 307500 D Stock Option (right to buy) 5.00 2019-02-20 4 D 0 30000 D 2023-07-16 Common Stock 30000 307500 D Stock Option (right to buy) 0.93 2019-02-20 4 A 0 22500 A 2024-02-20 Common Stock 22500 307500 D Stock Option (right to buy) 10.00 2019-02-20 4 D 0 60000 D 2024-09-05 Common Stock 60000 307500 D Stock Option (right to buy) 0.93 2019-02-20 4 A 0 45000 A 2024-02-20 Common Stock 45000 307500 D Stock Option (right to buy) 17.20 2019-02-20 4 D 0 75000 D 2025-09-04 Common Stock 75000 307500 D Stock Option (right to buy) 0.93 2019-02-20 4 A 0 56250 A 2024-02-20 Common Stock 56250 307500 D Stock Option (right to buy) 4.00 2019-02-20 4 D 0 30000 D 2027-05-01 Common Stock 30000 307500 D Stock Option (right to buy) 0.93 2019-02-20 4 A 0 22500 A 2024-02-20 Common Stock 22500 307500 D Vested in five annual instalments on anniversaries of date of grant. On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options. Reflects number of securities beneficially owned following all transactions reported on this Form 4/A. Fully vests on first anniversary of grant date. On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person. Vested 20% on 7/1/2010 and then in 20% instalments on each anniversary thereof. Vested in three equal annual instalments on the anniversary of the date of grant. This report on Form 4/A corrects an error with respect to the Amount of Securities Beneficially Owned Following Reported Transaction. /s/ Robert B. Kay 2019-05-31